VAXART (VXRT)
(Delayed Data from NSDQ)
$0.79 USD
-0.01 (-0.67%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $0.79 0.00 (0.50%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Income Statements
Fiscal Year end for VAXART, INC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7 | 0 | 1 | 4 | 10 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 7 | 0 | 1 | 4 | 10 |
Selling & Adminstrative & Depr. & Amort Expenses | 91 | 115 | 74 | 34 | 26 |
Income After Depreciation & Amortization | -83 | -115 | -73 | -30 | -16 |
Non-Operating Income | 3 | 8 | 4 | 0 | 0 |
Interest Expense | 1 | 1 | 1 | 2 | 2 |
Pretax Income | -82 | -108 | -70 | -32 | -18 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -82 | -108 | -70 | -32 | -19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -82 | -108 | -70 | -32 | -19 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -75 | -109 | -69 | -27 | -12 |
Depreciation & Amortization (Cash Flow) | 8 | 6 | 4 | 3 | 4 |
Income After Depreciation & Amortization | -83 | -115 | -73 | -30 | -16 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 144.82 | 127.68 | 121.45 | 88.30 | 21.57 |
Diluted EPS Before Non-Recurring Items | -0.57 | -0.84 | -0.58 | -0.36 | -0.86 |
Diluted Net EPS (GAAP) | -0.57 | -0.84 | -0.58 | -0.36 | -0.86 |
Fiscal Year end for VAXART, INC falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 6.40 | 2.18 | 3.25 | 2.10 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 6.40 | 2.18 | 3.25 | 2.10 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 22.66 | 26.25 | 20.15 | 19.92 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -16.26 | -24.07 | -16.90 | -17.82 |
Non-Operating Income | NA | 0.42 | 0.50 | 0.57 | 0.67 |
Interest Expense | NA | 0.61 | 0.80 | 0.87 | 0.21 |
Pretax Income | NA | -16.45 | -24.37 | -17.20 | -17.36 |
Income Taxes | NA | 0.02 | 0.05 | 0.17 | 0.04 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -16.47 | -24.42 | -17.38 | -17.40 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -16.47 | -24.42 | -17.38 | -17.40 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 184.70 | 168.81 | 144.82 | 152.03 |
Diluted EPS Before Non-Recurring Items | NA | -0.09 | -0.14 | -0.12 | -0.11 |
Diluted Net EPS (GAAP) | NA | -0.09 | -0.14 | -0.11 | -0.11 |